These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 31331008

  • 1. Melatonin and (-)-Epigallocatechin-3-Gallate: Partners in Fighting Cancer.
    Zhang L, He Y, Wu X, Zhao G, Zhang K, Yang CS, Reiter RJ, Zhang J.
    Cells; 2019 Jul 19; 8(7):. PubMed ID: 31331008
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Detrimental effect of cancer preventive phytochemicals silymarin, genistein and epigallocatechin 3-gallate on epigenetic events in human prostate carcinoma DU145 cells.
    Bhatia N, Agarwal R.
    Prostate; 2001 Feb 01; 46(2):98-107. PubMed ID: 11170137
    [Abstract] [Full Text] [Related]

  • 6. EGCG inhibits protein synthesis, lipogenesis, and cell cycle progression through activation of AMPK in p53 positive and negative human hepatoma cells.
    Huang CH, Tsai SJ, Wang YJ, Pan MH, Kao JY, Way TD.
    Mol Nutr Food Res; 2009 Sep 01; 53(9):1156-65. PubMed ID: 19662644
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Epigallocatechin-3-gallate prevents autoimmune-associated down- regulation of p21 in salivary gland cells through a p53-independent pathway.
    Dickinson D, Yu H, Ohno S, Thomas C, Derossi S, Ma YH, Yates N, Hahn E, Bisch F, Yamamoto T, Hsu S.
    Inflamm Allergy Drug Targets; 2014 Feb 01; 13(1):15-24. PubMed ID: 24329914
    [Abstract] [Full Text] [Related]

  • 9. Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents.
    Agarwal R.
    Biochem Pharmacol; 2000 Oct 15; 60(8):1051-9. PubMed ID: 11007941
    [Abstract] [Full Text] [Related]

  • 10. Epigallocatechin-3-gallate causes the p21/WAF1-mediated G(1)-phase arrest of cell cycle and inhibits matrix metalloproteinase-9 expression in TNF-alpha-induced vascular smooth muscle cells.
    Kim CH, Moon SK.
    Arch Biochem Biophys; 2005 Mar 15; 435(2):264-72. PubMed ID: 15708369
    [Abstract] [Full Text] [Related]

  • 11. Ablation of either p21 or Bax prevents p53-dependent apoptosis induced by green tea polyphenol epigallocatechin-3-gallate.
    Hastak K, Agarwal MK, Mukhtar H, Agarwal ML.
    FASEB J; 2005 May 15; 19(7):789-91. PubMed ID: 15764647
    [Abstract] [Full Text] [Related]

  • 12. Molecular pathway for (-)-epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells.
    Gupta S, Hussain T, Mukhtar H.
    Arch Biochem Biophys; 2003 Feb 01; 410(1):177-85. PubMed ID: 12559991
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate.
    Liang YC, Lin-Shiau SY, Chen CF, Lin JK.
    J Cell Biochem; 1999 Oct 01; 75(1):1-12. PubMed ID: 10462699
    [Abstract] [Full Text] [Related]

  • 14. Epigallocatechin-3-gallate inhibits cell cycle and induces apoptosis in pancreatic cancer.
    Shankar S, Suthakar G, Srivastava RK.
    Front Biosci; 2007 Sep 01; 12():5039-51. PubMed ID: 17569628
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Carbonyl reductase 1 as a novel target of (-)-epigallocatechin gallate against hepatocellular carcinoma.
    Huang W, Ding L, Huang Q, Hu H, Liu S, Yang X, Hu X, Dang Y, Shen S, Li J, Ji X, Jiang S, Liu JO, Yu L.
    Hepatology; 2010 Aug 01; 52(2):703-14. PubMed ID: 20683966
    [Abstract] [Full Text] [Related]

  • 19. Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells.
    Hastak K, Gupta S, Ahmad N, Agarwal MK, Agarwal ML, Mukhtar H.
    Oncogene; 2003 Jul 31; 22(31):4851-9. PubMed ID: 12894226
    [Abstract] [Full Text] [Related]

  • 20. Expression of NSAID-activated gene-1 by EGCG in head and neck cancer: involvement of ATM-dependent p53 expression.
    Kang SU, Lee BS, Lee SH, Baek SJ, Shin YS, Kim CH.
    J Nutr Biochem; 2013 Jun 31; 24(6):986-99. PubMed ID: 23017582
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.